Trevi Therapeutics, Inc.
TRVI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$48 | -$29 | -$29 | -$34 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $4 | $2 | $2 | $3 |
| Change in WC | $7 | -$4 | -$1 | $2 |
| Other Non-Cash | -$1 | -$1 | -$0 | $1 |
| Operating Cash Flow | -$38 | -$32 | -$28 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | -$1 | $0 |
| Inv. Purchases | -$98 | -$10 | -$126 | $0 |
| Inv. Sales/Matur. | $76 | $69 | $19 | $0 |
| Other Inv. Act. | $1 | $0 | $1 | $0 |
| Investing Cash Flow | -$22 | $59 | -$107 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$9 | -$6 | -$0 |
| Stock Issued | $61 | $2 | $105 | $21 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $12 | -$0 |
| Financing Cash Flow | $61 | -$8 | $111 | $21 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | $20 | -$24 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32 | $13 | $37 | $45 |
| End Cash | $34 | $32 | $13 | $37 |
| Free Cash Flow | -$38 | -$32 | -$28 | -$29 |